2022. Enhancing the Bioavailability of Quercetin by Concomitant Administration with Enzyme Inhibitor. Journal of Pharmaceutical Negative Results. (Oct. 2022), 981–991. DOI:https://doi.org/10.47750/pnr.2022.13.S06.131.